Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Pharmaceutics|May 28, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction PredictionsHelena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, et al.
Pharmaceutical Research|December 29, 2016
Modeling the Effect of the Selective S1P<sub>1</sub> Receptor Modulator Ponesimod on Subsets of Blood LymphocytesDominik Lott, Andreas Krause, Christian A Seemayer, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and DigoxinNina Hanke, Sebastian Frechen, Daniel Moj, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's diseaseThorsten Lehr, Alexander Staab, Christiane Tillmann, et al.
Current Medical Research and Opinion|January 3, 2012
Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justificationAndreas Clemens, Sebastian Haertter, Jeffrey Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2021
Cytokine Release Syndrome By T-cell-Redirecting Therapies: Can We Predict and Modulate Patient Risk?Arthur J Van De Vyver, Estelle Marrer-Berger, Ken Wang, et al.
Pharmaceutics|December 16, 2020
Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene InteractionsSimeon Rüdesheim, Jan-Georg Wojtyniak, Dominik Selzer, et al.
Psychoneuroendocrinology|January 27, 2018
How to disentangle psychobiological stress reactivity and recovery: A comparison of model-based and non-compartmental analyses of cortisol concentrationsRobert Miller, Jan-Georg Wojtyniak, Lisa J Weckesser, et al.
Pharmaceutics|September 26, 2020
Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric PatientsLukas Kovar, Andreas Weber, Michael Zemlin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2021
Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound?Johanna Weiss, Kathrin Isabelle Foerster, Maria Weber, et al.
Pageof 13